Contract Notice Detail

Summary Information Summary Information Base Total Price: 213,750.000000 Euro   Request Reference: 010100162020   Request Name: aquisição de bevacizumab   Phase: Tendering Phase State: Awarded Description: aquisição de bevacizumab   Procedure Type: VortalGOV - Urgent Open Tender   Object of the Contract Object of the Contract Type of Contract: Supplies Acquisition   Description: concurso público urgente n.º 010100162020 - aquisição de bevacizumab   Main Object CPV Main Category: Av Bissaia Barreto Praceta Prof. Mota Pinto PORTUGAL   CPV Main Vocabulary 33698000-9 - Clinical products   CPV Supplementary Vocabulary   Additional Classifications List   Scheduling Scheduling Request online publishing date: 10/6/2020 1:52 PM (UTC +1 hour)   National official publishing date and time (DR): 10/6/2020 10:35 AM (UTC +1 hour)   Due datetime for receiving replies: 10/9/2020 10:36 AM (UTC +1 hour)   Financial Settings Financial Settings Define Advance Payments? No   Define Warranties? No   Contract Documents Contract Documents Document Name Description Doc Classification CAD ENCARGOS..pdf CAD ENCARGOS..pdf Download programa_do_concurso.pdf programa_do_concurso.pdf Download declaracao_vortal_2020.pdf declaracao_vortal_2020.pdf Download anuncio_diario_republica.pdf anuncio_diario_republica.pdf Download Award and Contract Information Award and Contract Information   Award Award Date Award Value Award State       PT1.AWD.1144183 10/21/2020 157,950.00 Euro Active           Awarded Company Contract Value Document(s)             AMGEN-BIOFARMACEUTICA, LDA. 157,950.00 Euro   Legal, economic, financial and technical information The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons? No   Questionnaire Questionnaire     1   Questionário   1.1         Secção   1.1.1         Articulado da Consulta * (Os valores indicados não incluem o IVA)           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           Reference10067022 Internal Reference DescriptionBEVACizumab 25 mg/mL Sol inj Fr 4 mL IV Qty150,000000 Unitamp Price per Unit Total           Reference10067015 Internal Reference DescriptionBEVACizumab 25 mg/mL Sol inj Fr 16 mL IV Qty300,000000 Unitamp Price per Unit Total Evaluation Evaluation Evaluation General Settings Evaluation General Settings Evaluation guideline MostEconomicallyAdvantageousTender   Evaluation Method Manual   Evaluation Items Evaluation Items Name Lot Critérios da Avaliação       Peso (%)**   1   preço 100   Define tie breaking rules? YesNo     Public Messages Public Messages Type Reference Subject Date No items found...